Thalassemia Patients in Kerala Face Shortage of Essential Leukocyte Filters and Iron Chelation Drugs
Thalassemia patients in Kerala are reporting a decline in hemoglobin levels due to a shortage of leukocyte filter sets, which prevent adverse reactions during blood transfusions. Additionally, iron chelation drugs, necessary to remove excess iron deposited in organs after transfusions, have been unavailable for a year. While the government has issued orders for local procurement, authorities are allegedly ignoring these directives. The shortage is attributed to financial crunches, though new tenders have been called. Thalassemia is an inherited blood disorder where the body fails to produce enough hemoglobin, requiring lifelong regular transfusions to maintain oxygen levels in the blood.
Key Points
- Thalassemia is a genetic disorder affecting hemoglobin production in red blood cells, leading to chronic anemia.
- Regular blood transfusions lead to iron overload, necessitating iron chelation therapy to protect vital organs like the heart and liver.
- Leukocyte filters are critical during transfusions to minimize adverse immune reactions and maintain hemoglobin stability.
- The current shortage of these medical supplies in Kerala poses a severe health risk to the patient community.
Exam Facts
- Thalassemia is an inherited blood disorder.
- Hemoglobin is the protein in RBCs that transports oxygen to tissues.
- Iron chelation therapy is the standard treatment for iron overload following frequent transfusions.
Read it. Retain it. Recall it.
Get spaced-repetition flashcards, daily quizzes and offline access — free on Android.